Tipsheet
What matters at India’s listed companies
Earnings · Chemicals · Mid cap

Jubilant Ingrevia Q1 FY27 transcript: nothing new

The July 23 call was already aired live. The filed transcript is a routine record, not a catalyst.

5 earlier stories on Jubilant Ingrevia Ltd.
Mkt cap₹9,902 cr
P/E35.63×
ROE8.58%
Debt / eq.0.26
Div yld0.40%
Q1 FY27 Quarter under review

What's new

  • Jubilant Ingrevia filed the Q1 FY27 earnings call transcript on July 23, 2026.
  • The document is backward-looking and contains no new material information.
  • It is a record for investors who missed the live call.

Why this matters

This is a routine regulatory compliance step. Transcripts rarely move markets because the content was already disseminated during the live call. The next catalyst for the stock will be fresh operational data, not this record.

What we're watching

  • No new forward-looking indicators from this transcript.
  • Future updates on the ₹3,500 cr CDMO pipeline.
  • Resolution of the agro client's financial distress.

The full read

Jubilant Ingrevia's Q1 FY27 call transcript is out. It adds nothing to what was said live on July 23 — the earnings release and live access already gave investors the full picture. In Q4 FY26 the company hit its highest profit in 14 quarters and flagged a ₹3,500 cr CDMO pipeline, but this document is backward-looking and procedural. Hardly a market mover.

Questions answered

When was the Q1 FY27 earnings call held?
The call was held on July 23, 2026.
Does the transcript contain any new information?
No. It is a backward-looking record of information already discussed live.
Who participated in the call?
Management and several institutional investors and analysts participated.
Why is this filing important?
It is a routine regulatory compliance requirement, not a market-moving event.
Mentioned: Jubilant Ingrevia · Q1 FY27 · July 23, 2026
Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Company snapshot

Jubilant Ingrevia Ltd.

Chemicals
₹11,837 cr
P/E 38.35×

Latest quarter · Jun 2026

Sales₹1,300 cr
Net profit₹106 cr
Op. margin+15.3%
EPS₹6.71

Strength & growth

Debt / equity0.26×
Current ratio1.32×
  1. 27 Jul 2026 · 8:08 PM IST Jubilant Ingrevia Q1 FY27 transcript: nothing new
  2. 60d ago Jubilant Ingrevia's call transcript quantifies a ₹3,500 cr CDMO pipeline
  3. 63d ago Jubilant Ingrevia's $300M agro client faces financial distress
  4. 63d ago Jubilant Ingrevia posts highest profit in 14 quarters on volume recovery
  5. 63d ago Jubilant Ingrevia hits 14-quarter revenue high, guides for more